These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15320711)

  • 1. The selection and design of GPCR ligands: from concept to the clinic.
    Ashton M; Charlton MH; Schwarz MK; Thomas RJ; Whittaker M
    Comb Chem High Throughput Screen; 2004 Aug; 7(5):441-52. PubMed ID: 15320711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
    Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
    Bissantz C; Schalon C; Guba W; Stahl M
    Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G Protein-Coupled Receptors: target-based in silico screening.
    Senderowitz H; Marantz Y
    Curr Pharm Des; 2009; 15(35):4049-68. PubMed ID: 20028321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M; Hirokawa T
    J Chem Inf Model; 2014 Nov; 54(11):3153-61. PubMed ID: 25350693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico guided discovery of novel CCR9 antagonists.
    Zhang X; Cross JB; Romero J; Heifetz A; Humphries E; Hall K; Wu Y; Stucka S; Zhang J; Chandonnet H; Lippa B; Ryan MD; Baber JC
    J Comput Aided Mol Des; 2018 Apr; 32(4):573-582. PubMed ID: 29582229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Library design and virtual screening using multiple 4-point pharmacophore fingerprints.
    Mason JS; Cheney DL
    Pac Symp Biocomput; 2000; ():576-87. PubMed ID: 10902205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of structure-based virtual screening studies and characterization of identified active compounds.
    Ripphausen P; Stumpfe D; Bajorath J
    Future Med Chem; 2012 Apr; 4(5):603-13. PubMed ID: 22458680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking Finds GPCR Ligands in Dark Chemical Matter.
    Ballante F; Rudling A; Zeifman A; Luttens A; Vo DD; Irwin JJ; Kihlberg J; Brea J; Loza MI; Carlsson J
    J Med Chem; 2020 Jan; 63(2):613-620. PubMed ID: 31846328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different strategies for designing GPCR and kinase targeted libraries.
    Lowrie JF; Delisle RK; Hobbs DW; Diller DJ
    Comb Chem High Throughput Screen; 2004 Aug; 7(5):495-510. PubMed ID: 15320714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design of GPCR ligands using physicogenetics and chemogenomics--principles and case studies.
    Frimurer TM; Högberg T
    Curr Top Med Chem; 2011; 11(15):1882-901. PubMed ID: 21470174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
    Wada M; Kanamori E; Nakamura H; Fukunishi Y
    J Chem Inf Model; 2011 Sep; 51(9):2398-407. PubMed ID: 21848279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
    Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
    J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and virtual screening of target libraries.
    Rognan D
    J Physiol Paris; 2006; 99(2-3):232-44. PubMed ID: 16459061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Guided Screening for Functionally Selective D
    Männel B; Jaiteh M; Zeifman A; Randakova A; Möller D; Hübner H; Gmeiner P; Carlsson J
    ACS Chem Biol; 2017 Oct; 12(10):2652-2661. PubMed ID: 28846380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.